Genomic aberrations in pediatric diffuse intrinsic pontine gliomas

Neuro-Oncology

Volumn 14, Issue 3, 2012, Pages 326-332

  Warren, Katherine E ^a   Killian, Keith ^b   Suuriniemi, Miia ^b   Wang, Yonghong ^b   Quezado, Martha ^b   Meltzer, Paul S ^b  

^a Center for Cancer Research   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

brainstem glioma; DIPG; genomics; microarray; pontine glioma

Indexed keywords

ADOLESCENT; ARTICLE; AUTOPSY; CHILD; CHILDHOOD CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; DIFFUSE INTRINSIC PONTINE GLIOMA; DNA EXTRACTION; FEASIBILITY STUDY; FEMALE; GENE DELETION; GENE DOSAGE; GEOGRAPHICAL VARIATION (SPECIES); GLIOMA; HISTOLOGY; HUMAN; HYBRIDIZATION; MALE; ONCOGENE; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

ADOLESCENT; BIOPSY; BRAIN STEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA, NEOPLASM; HUMANS; PARAFFIN EMBEDDING; PONS; PONTINE GLIOMA;

EID: 84859559031     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nor190     Document Type: Article

References (24)

1. Wilkinson R, Harris J. Moral and legal reasons for altruism in the case of brainstem biopsy in diffuse glioma. Br J Neurosurgery. 2008;22:617-618.
2. Louis D, Rubio M-P, Correa K, Gusella J, von Deimling A. Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J Neuropath Exp Neurol. 1993;52:507-515. (Pubitemid 23269199)
3. Gilbertson R, Hill D, Hernan R, et al. ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma. Clin Cancer Res. 2003;9:3620-3624. (Pubitemid 37169226)
4. Zarghooni M, Bartels U, Lee E, et al. Whole-genomic profiling of diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor a and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol. 2010;28:1337-1344.
5. Russell D, Rubinstein L. Pathology of tumours of the nervous system. Baltimore: Williams & Wilkins; 1989.
6. Fuller G, Bigner S. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res. 1992;276:299-306.
7. Cheng Y, Ng H, Zhang S, et al. Genetic alterations in pediatric highgrade gliomas. Human Pathol. 1999;30:1284-1290. (Pubitemid 29534288)
8. Verhaak R, Hoadley K, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98-110.
9. Paugh B, Qu C, Jones C, et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol. 2010;28:3061-3068.
10. Barrow J, Adamowicz-Brice M, Cartmill M, et al. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol. 2011;13:212-222.
11. Pollack I, Jakacki R, Blaney S, et al. Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a pediatric brain tumor consortium report. Neuro Oncol. 2007;9:145-160. (Pubitemid 46580316)
12. Geyer J, Stewart C, Kocak M, et al. A Phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas and supratentorial malignant gliomas [published online ahead of print August 16, 2010]. Eur J Cancer. 2010.
13. Haas-Kogan D, Banerjee A, Kocak M, et al. Phase I trial of tipifarnib in children with newly diagnosed diffuse intrinsic brainstem gliomas. Neuro Oncol. 2008;10:341-347.
14. Alers J, Rochat J, Krijtenburg P, van Dekken H, Raap A, Rosenberg C. Universal linkage system: An improved method for labeling archival DNA for comparative genomic hybridization. Genes Chromosomes Cancer. 1999;25:301-305. (Pubitemid 29266700)
15. Nishizaki T, Ozaki S, Harada K, et al. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes Cancer. 1998;21:340-346. (Pubitemid 28165042)
16. Burton E, Lamborn K, Feuerstein B, et al. Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res. 2002;62:6205-6210. (Pubitemid 35244472)
17. Inda M, Fan X, Munoz J, et al. Chromosomal abnormalities in human glioblastomas: gain in chromosome 7p correlating with loss in chromosome 10q. Mol Carcinog. 2003;36:6-14. (Pubitemid 36055810)
18. Lee J-J, Kim B, Park M-J, et al. PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation. Cell Death and Differentiation. 2011;18:666-677.
19. Ivanchuk S, Mondal S, Dirks P, Rutka J. The INK4A/ARF locus: Role in cell cycle control and apoptosis and implications for glioma growth. J Neuro-Oncol. 2001;51:219-229. (Pubitemid 32479296)
20. Hermanson M, Funa K, Hartman M, et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 1992;52:3213-3219.
21. Nister M, Libermann T, Betsholtz C, et al. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res. 1998;48:3910-3918.
22. Chojnacki A, Weiss S. Production of neurons, astrocytes and oligodendrocytes from mammalian CNS stem cells. Nat Protoc. 2008;3:935-940. (Pubitemid 351818681)
23. Dearth R, Cui X, Kim H-J, Hadsell D, Lee A. Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle. 2007;6:705-713. (Pubitemid 46535683)
24. Vranova V, NeCesalova E, Kuglik P, et al. Screening of genomic imbalances in glioblastoma multiforme using high-resolution comparative genomic hybridization. Oncology Reports. 2007;17:457-464.